Back to trial detailsIntake questionnaire
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Applying to Yale University Cancer Center · New Haven, Connecticut
Answer a few short questions to share with the research team.
0 of 3 answered